Skip to main navigation
Skip to search
Skip to main content
Research Profiles at Washington University School of Medicine Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
An analysis of FDA-approved drugs for oncology
Michael S. Kinch
Department of Biochemistry & Molecular Biophysics
Institute of Clinical and Translational Sciences (ICTS)
Siteman Cancer Center
Center for Drug Discovery
Office of Medical Research
Research output
:
Contribution to journal
›
Short survey
›
peer-review
72
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'An analysis of FDA-approved drugs for oncology'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
FDA-approved Drugs
100%
Oncology
100%
Targeting Cancer
50%
Pharmaceutical Companies
50%
Leading Causes of Death
50%
New Drugs
50%
Kinase Target
50%
Oncology Drug Development
50%
Clinical Research
50%
New Medicines
50%
Targeting Strategies
50%
Biotechnology Industry
50%
Preclinical Research
50%
Orphan Indication
50%
Recent Trends
50%
Oncology Drugs
50%
Patent Research
50%
Medicine and Dentistry
Malignant Neoplasm
100%
Oncology
100%
Medicine
33%
Clinical Research
33%
Biological Product
33%
Phosphotransferase
33%
Orphan
33%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Phosphotransferase
50%
Biological Product
50%
Clinical Research
50%
Cancer Drug Development
50%